文献库，生知库 | 链接生命科学的每一步

日期影响因子

Development of a pre-glycoengineered CHO-K1 host cell line for the expression of antibodies with enhanced Fc mediated effector function

开发预糖工程 CHO-K1 宿主细胞系，用于表达具有增强 Fc 介导效应功能的抗体

影响因子:5.6

doi:10.1080/19420862.2017.1405203

Oliver Popp, Samuel Moser, Jörg Zielonka, Petra Rüger, Silke Hansen, Oliver Plöttner

细胞生物学

发表日期：2018

文献求助收藏

Cergutuzumab amunaleukin (CEA-IL2v), a CEA-targeted IL-2 variant-based immunocytokine for combination cancer immunotherapy: Overcoming limitations of aldesleukin and conventional IL-2-based immunocytokines

Cergutuzumab amunaleukin (CEA-IL2v)，一种用于联合癌症免疫治疗的 CEA 靶向 IL-2 变体免疫细胞因子：克服阿地白介素和传统 IL-2 免疫细胞因子的局限性

期刊:Oncoimmunology

doi:10.1080/2162402X.2016.1277306

Christian Klein, Inja Waldhauer, Valeria G Nicolini, Anne Freimoser-Grundschober, Tapan Nayak, Danielle J Vugts, Claire Dunn, Marije Bolijn, Jörg Benz, Martine Stihle, Sabine Lang, Michaele Roemmele, Thomas Hofer, Erwin van Puijenbroek, David Wittig, Samuel Moser, Oliver Ast, Peter Brünker, Ingo H G

发表日期：2017

文献求助收藏

XGFR*, a novel affinity-matured bispecific antibody targeting IGF-1R and EGFR with combined signaling inhibition and enhanced immune activation for the treatment of pancreatic cancer

XGFR* 是一种新型亲和力成熟的双特异性抗体，靶向 IGF-1R 和 EGFR，具有联合信号抑制和增强免疫激活作用，用于治疗胰腺癌

影响因子:5.6

doi:10.1080/19420862.2016.1160989

Juergen M Schanzer, Katharina Wartha, Ekkehard Moessner, Ralf J Hosse, Samuel Moser, Rebecca Croasdale, Halina Trochanowska, Cuiying Shao, Peng Wang, Lei Shi, Tina Weinzierl, Natascha Rieder, Marina Bacac, Carola H Ries, Hubert Kettenberger, Tilman Schlothauer, Thomas Friess, Pablo Umana, Christian

发表日期：2016

文献求助收藏

A novel glycoengineered bispecific antibody format for targeted inhibition of epidermal growth factor receptor (EGFR) and insulin-like growth factor receptor type I (IGF-1R) demonstrating unique molecular properties

一种新型糖基化双特异性抗体形式，用于靶向抑制表皮生长因子受体 (EGFR) 和胰岛素样生长因子受体 I 型 (IGF-1R)，具有独特的分子特性

期刊:Journal of Biological Chemistry

doi:10.1074/jbc.M113.528109

Juergen M Schanzer, Katharina Wartha, Rebecca Croasdale, Samuel Moser, Klaus-Peter Künkele, Carola Ries, Werner Scheuer, Harald Duerr, Sandra Pompiati, Jan Pollman, Jan Stracke, Wilma Lau, Stefan Ries, Ulrich Brinkmann, Christian Klein, Pablo Umana

Insulin Receptor

发表日期：2014

文献求助收藏

Increasing the efficacy of CD20 antibody therapy through the engineering of a new type II anti-CD20 antibody with enhanced direct and immune effector cell-mediated B-cell cytotoxicity

通过设计新型 II 型抗 CD20 抗体来增强直接和免疫效应细胞介导的 B 细胞细胞毒性，从而提高 CD20 抗体治疗的疗效

影响因子:21

doi:10.1182/blood-2009-06-225979

Ekkehard Mössner, Peter Brünker, Samuel Moser, Ursula Püntener, Carla Schmidt, Sylvia Herter, Roger Grau, Christian Gerdes, Adam Nopora, Erwin van Puijenbroek, Claudia Ferrara, Peter Sondermann, Christiane Jäger, Pamela Strein, Georg Fertig, Thomas Friess, Christine Schüll, Sabine Bauer, Joseph Dal

细胞生物学

发表日期：2010

文献求助收藏